Joint Statement from Pyxis Partners and Rx4good on New Details Regarding FDA Requirements on Diversity Action Plans for Certain Clinical Studies
As partners dedicated to advancing diversity and inclusivity in clinical trials, Pyxis Partners and Rx4good welcome the recently released U.S. Food and Drug Administration (FDA) draft guidance on diversity action plan requirements for…